We are excited to announce the expansion of WuXi AppTec’s facilities in San Diego, Calif. Our newly expanded facility will establish a center of excellence in screening, discovery biology, pharmacology, and small molecule process R&D including phase I GMP manufacturing. The expansion will provide key elements of WuXi’s small molecule capability and technology platform under one roof, further enhancing services to North American pharmaceutical and biotech industries. WuXi will also add extensively from the local talent base, further contributing to regional economic growth.
The expansion will enable us to better serve our US and global customers and contribute to the growth and success of the dynamic San Diego biotech ecosystem. Together with our ecosystem partners, we will continue to strengthen WuXi’s capability and technology enable platform to expedite the discovery and development of new medicines for patients worldwide, and for a future where every drug can be made and every disease treated.